Author: Dr. David Lowemann

FDA: Pharmacies Can Compound Weight-Loss Med

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list. What prompted the FDA to reconsider its decision?… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on October 15, 2024

Long-Term Care Out of Reach for 6.5 Million Seniors

About 6.5 million “Near Dual” seniors are struggling to afford long-term care as they grow older and more frail, a new study warns. “Near Dual” seniors are those who are eligible for Medicare but are only at the cusp of eligibility for Medicaid, the federal/state insurance… Read Full Article (External Site) Dr. David LowemannDr. David […]

Published on October 14, 2024

GLP-1 Weight-Loss Meds May Lower Teens’ Suicide Risk

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts. But a new study involving more than 54,000 U.S. adolescents found no such… Read Full Article (External Site) Dr. David LowemannDr. David […]

Published on October 14, 2024